Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06926166 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Human Genes and Microbiota in Early Life

Study acronym: HuGME
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Lead sponsor: Guangzhou Women and Children's Medical Center to Guangzhou Women and Children's Medical Center Show 5 more changesShow less
    • Eligibility criteria revised
    • Secondary endpoints: details revised at 2 of 8 entries
    • Study description expanded, about 6 words
    • Site details revised
    • Publications: details revised at 5 of 5 entries
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The long-term goal of the Human Genes and Microbiota in Early Life (HuGME) is to explore the short- and long-term effects of maternal microbiota during pregnancy and the microbiota colonization of their offspring early in life and their interaction with the host on maternal-offspring health consequences in later life in the born in Guangzhou cohort study in China. Identification of the effect of microbiota in early life, as well as environmental factors and microbe-host interaction, will lead to a better understanding of disease pathogenesis and provide a foundation for targeted mechanistic investigation into the consequences of microbial-host crosstalk for long-term health. It also can result in new strategies to predict and prevent diseases in later life.
Trial Details
NCT Number NCT06926166
Lead Sponsor Guangzhou Women and Children's Medical Center
Conditions
(from sponsor)		 Host and Microbiome, Pregnancy Outcomes, Pregnancy Complications, Neurodevelopmental Disorders, Immune Development, Childhood Obesity, Type 2 Diabetes
Related terms Diabetes Mellitus, Type 2, Neurodevelopmental Disorders, Pediatric Obesity, Pregnancy Complications
Enrollment 20,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov